Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by Novartis Ireland Limited .
Filed returns
7
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Sep–Dec 2020 | Novartis Ireland Limited | Health | Expansion of Newborn Screening (Legislation) | 2 | On lobbying.ie |
| Sep–Dec 2020 | Novartis Ireland Limited | Health | Timely access to innovative new products, IP, EU Pharma Strategy (Legislation) | 1 | On lobbying.ie |
| May–Aug 2020 | Novartis Ireland Limited | Health | Supporting intellectual property incentives in rare diseases, funding for new medicines, EU Pharmaceutical Strategy, (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2019 | Novartis Ireland Limited | Health | Reimbursement of new Medicines, Intellectual Property, need for new approaches in cell & gene therapy (Matters involving public funds) | 4 | On lobbying.ie |
| Jan–Apr 2018 | Novartis Ireland Limited | Health | Strong Intellectual Property protection is a critical pre-requisite to maintaining an environment where innovation can thrive in healthcare (Legislation) | 1 | On lobbying.ie |
| Sep–Dec 2016 | Novartis Ireland Limited | Health | Making Heart Failure a public policy priority (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2016 | Novartis Ireland Limited | Health | Make heart failure (HF) a health policy priority - update on initiatives taking place in the West (Public policy or programme) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 7 | 100.0% |